Biohaven

02/20/2026

On February 23, the .S. Food and Drug Administration will host its virtual Rare Disease Day, “Moving Forward. Looking Ahead. An Event for Patients.” Patients, families, care partners and advocates are encouraged to attend and learn more about the FDA’s initiatives to advance medical product development for rare disease.
Learn more and register here: https://bit.ly/4kHLo6l

The public meeting will be held on February 23, 2025, from 9 a.m. to 4 p.m ET.

02/18/2026

Emma’s journey with Graves’ disease reflects the challenges of acceptance and learning to live with a chronic condition. Her story reminds us that a diagnosis does not define a person.
To learn more about Graves’ disease, visit: UnmaskGravesDisease.com

02/11/2026

On International Day of Women and Girls in Science, we’re celebrating the women at Biohaven who lead, innovate and inspire.

02/06/2026

This , we honor the strength, resilience and courage of the patients who inspire us. You guide our mission to advance science, tackle tough challenges and deliver treatments that make a meaningful difference.

01/29/2026

At Biohaven, . We’re dedicated to advancing science with the speed and rigor that patients expect and deserve.
See what we’re working on to make a difference: https://bit.ly/4jOEmL8

01/27/2026

IgA nephropathy (IgAN) is a rare, serious kidney disease that often affects young adults and can lead to kidney failure. With no FDA-approved treatments that target the underlying cause, there’s an urgent need for new therapies and greater awareness.
To learn more about IgAN, its impact and the need for innovative treatment approaches, visit: https://bit.ly/4904Vuy

01/21/2026

This National Healthy Weight Week, we’re highlighting the importance of maintaining a healthy weight for overall health and well-being.

We are advancing research exploring an innovative approach of targeting myostatin, a natural protein that when blocked increases skeletal muscle and reduces fat. Our goal is to enhance lean muscle, reduce fat and supporting overall metabolic health.

01/19/2026

During a conversation with Jim Cramer on CNBC’s Mad Money, our CEO shares how our work across multiple therapeutic areas, including precision immunology, obesity and epilepsy is guided by one belief: patients can’t wait. Watch here: https://brnw.ch/21wZcMD

01/14/2026

TUNE IN: Our CEO will be joining Jim Cramer on CNBC's Mad Money to highlight our plans in 2026 for our diversified pipeline. cnbc.com/mad-money/

01/08/2026

People living with Graves’ disease are navigating challenges that aren’t always visible. Anxiety and fatigue can take a real toll. Sometimes, support looks like checking in, helping with daily tasks or simply showing compassion. Learn more and help unmask the realities of Graves’ disease at UnmaskGravesDisease.com

01/06/2026

January is Thyroid Awareness Month, a time to shine a light on thyroid health and the challenges faced by those living with thyroid conditions like Graves’ disease. Graves’ disease is an autoimmune disorder that attacks the thyroid and can have serious, often invisible effects. We want to thank Kim for sharing her story and helping raise awareness. Learn more about our research: https://brnw.ch/21wYRQh

12/30/2025

This year at Biohaven, our focus never wavered. Advancing therapies and tackling tough challenges, 2025 was all about progress and purpose. As we head into 2026, we’re excited to keep pushing science forward and delivering hope to the patients and families who inspire everything we do.